Angioplasty Balloons Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Angioplasty balloons are specialized catheters with inflatable tips used to restore blood flow through blocked or narrowed arteries, typically during PCI procedures. The global market has been estimated at roughly $2.7 billion to $2.9 billion in 2025 across various industry analyses, with projections extending toward $3.4 billion or higher by the early 2030s depending on the forecast period and methodology. The market covers several balloon types including standard plain-old-balloon angioplasty (POBA) devices, drug-eluting balloons (DEB), scoring balloons, and cutting balloons.

• •Market valued at approximately $2.88 billion in 2025, with industry projections ranging from roughly $2.6 billion to $3.5 billion depending on source and methodology
• •Products include plain balloons, drug-eluting balloons, cutting balloons, and scoring balloons, each designed for specific clinical scenarios
• •No official government statistical agency publishes authoritative baseline figures for this market; available data originates from independent commercial research firms

The primary driver of market expansion is the global rise in cardiovascular disease burden, fueled by aging demographics, sedentary lifestyles, and increasing prevalence of diabetes and hypertension. Growing preference for minimally invasive procedures over open-heart surgery, combined with improving healthcare infrastructure in emerging economies, is expanding the addressable patient population. Technological advancements such as drug-coated balloons that reduce restenosis rates continue to support procedural adoption and market value growth.

• •Rising global incidence of coronary artery disease driven by aging populations, dietary factors, and metabolic disorders
• •Shift toward minimally invasive interventional cardiology as a safer, faster-recovery alternative to surgical options
• •Expanding indications for drug-eluting balloons and improved reimbursement landscapes supporting procedural volumes

North America currently represents the largest regional market, supported by high healthcare spending, established interventional cardiology infrastructure, and favorable reimbursement policies. Europe follows as a significant market, while Asia-Pacific is the fastest-growing region due to rising cardiac disease prevalence, improving hospital capacity, and growing medical device adoption in countries such as China and India. By product type, drug-eluting balloons have been gaining share over conventional balloons due to superior clinical outcomes in certain lesion types.

• •North America leads in market share, supported by advanced healthcare infrastructure and widespread adoption of interventional cardiology
• •Asia-Pacific is the fastest-growing region, driven by rising cardiovascular disease burden and expanding access to catheterization laboratories
• •Drug-eluting balloons represent an increasingly important product segment as clinical evidence supports reduced rates of restenosis

What are the recent trends and outlook?

The market is moving toward advanced balloon technologies such as bioabsorbable scaffolds and next-generation drug-coated balloons designed to further minimize vessel recoil and restenosis. Integration of imaging guidance and personalized treatment planning is expected to influence procedural selection and device utilization patterns. Over the forecast horizon, incremental market growth is anticipated as device manufacturers pursue regulatory clearances in additional territories and healthcare systems continue prioritizing outpatient and minimally invasive cardiac care models.

• •Development of next-generation drug-coated balloons with improved drug pharmacokinetics and vessel healing profiles
• •Growth in emerging markets as hospital catheterization laboratory networks expand and interventional cardiology training programs proliferate
• •Potential for modest pricing pressure as generics and regional manufacturers enter the market in lower-income countries